Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-19

Clinical Trial Update: Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Aquamin F assessing its effect on reducing NSAID use in osteoarthritis of the knee, spanning Phase 1 and Phase 2, and now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aquamin F

Snippet

Sponsor: Marigot Ltd. | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: COMPLETED